Clinical Trials in Texas

Showing 2121-2140 of 7,265 trials

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

NCT02781883

The primary objectives of this study are to assess: (1) whether the combination of BP1001 plus venetoclax plus decitabine provides greater efficacy (Complete Remission \[CR\], Complete Remission with incomplete hematologic recovery \[CRi\], Complete Remission with partial hematologic recovery \[CRh\], than venetoclax plus decitabine alone (by historical comparison) in participants with untreated AML that cannot or elect not to be treated with more intensive chemotherapy; (2) whether BP1001-based treatment provides greater efficacy (CR, CRi, CRh) than intensive chemotherapy (by historical comparison) in participants with refractory/relapsed AML.

Acute Myeloid Leukemia (AML)

Bio-Path Holdings, Inc.108 participantsStarted May 2016

Los Angeles, California, United States • Augusta, Georgia, United States • Fairway, Kansas, United States +6 more locations

COMPLETEDNA13 miles

Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System

NCT01726257

The objective of this study is to assess the safety and effectiveness of the Endologix Nellix® System for the endovascular repair of infrarenal abdominal aortic aneurysms (AAA).

Abdominal Aortic Aneurysm (AAA)

Endologix333 participantsStarted Dec 2013

Tucson, Arizona, United States • San Diego, California, United States • New Haven, Connecticut, United States +27 more locations

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System

Find Trials by Condition in Texas

Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement

ViBone in Cervical and Lumbar Spine Fusion

NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC

A Phase 2b Study of Icosabutate in Fatty Liver Disease

A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer

LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris

Study of LP-184 in Patients With Advanced Solid Tumors

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer

Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome

Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours

Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination

Trial of DFP-14927 in Advanced Solid Tumors

EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPC

Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice

TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer

An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice